ABCB1 and acute myeloid leukemia: Approximately 50% of AML patients have blast cells that express ABCB1, and its overexpression is associated with lower complete remission (CR) rates; treatment with chemotherapy combining an anthracycline with cytarabine has higher relapse rates.